Treatment of deep vein thrombosis and pulmonary embolism

Archives of Hellenic Medicine

Volumn 17, Issue SUPPL. A, 2000, Pages

  Samama, M M ^a  

^a HÔTEL DIEU   (France)

Author keywords

Low molecular weight heparins; Pulmonary embolism; Unfractionated heparin; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE; UROKINASE;

ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DISEASE DURATION; DOSE RESPONSE; HUMAN; LABORATORY DIAGNOSIS; LIFE EXPECTANCY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PATIENT MONITORING; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0034437844     PISSN: 11053992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Antithrombotic therapy for venous thromboembolic disease. Sixth ACCP Consensus Conference on antithrombotic therapy
2. Anti-Xa monitoring during treatment with low molecular weight heparin or danaparoid: Inter-assay variability
3. Anti-Xa monitoring: Inter-assay variability
4. A standard heparin nomogram for the management of heparin therapy
5. Dose ranging trial of enoxaparin of unstable angina results of TIMI IIA
6. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home
7. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis
8. Prevention and treatment of venous thrombosis and pulmonary embolism
9. Venous thromboembolism: State of the Art
10. Outpatient treatment of deep vein thrombosis: Translating clinical trials in to practice
11. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis
12. A meta-analysis comparing low molecular weight heparins with unfractionated heparin in the treatment of venous thromboembolism